网站主页 >> CAS数据库列表 >> 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
|
|
|
- CAS号:
- 356783-10-3
- 英文名:
- 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
- 英文别名:
- T-705RTP sodium;T-705RTP Sodium Salt (>75%);T 705RTP sodium,T705RTP sodium;6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
- 中文名:
- 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
- 中文别名:
- 化合物 T13075L
- CBNumber:
- CB96018446
- 分子式:
- C10H16FN3NaO15P3
- 分子量:
- 553.15
- MOL File:
- 356783-10-3.mol
|
|
|
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)化学性质
-
熔点:
-
>123°C (dec.)
-
|
-
储存条件:
-
Hygroscopic, -20°C Freezer, Under inert atmosphere
-
|
-
溶解度:
-
Water (Slightly)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Pale Yellow to Pale Beige
-
|
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)性质、用途与生产工艺
T-705RTP sodium 是一种具有具有选择性和 GTP 竞争性的流感病毒 RNA 聚合酶 (RNA polymerase) 抑制剂，IC50 为 0.14 μM，Ki 为 1.52 μM。T-705RTP sodium 是 T-705 的活性三磷酸盐代谢产物，具有有效的抗流感病毒活性。
T-705RTP sodium and T-705RMP are detected in MDCK cells treated with T-705. T-705RTP sodium inhibits influenza virus RNA polymerase activity in a dose-dependent and a GTP-competitive manner.
T-705RTP sodium inhibits the incorporation of ATP and GTP in a competitive manner with K
i
values of 7.72 and 1.56 μM, respectively. T-705RTP sodium inhibits the incorporation of CTP in a mixed-type manner with a K
i
value of 11.3 μM, and also inhibits the incorporation of UTP in a noncompetitive manner.
The incorporation of a single molecule of T-705RTP sodium (10-1000 μM) inhibits influenza virus RNA strand extension.
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
上下游产品信息
上游原料
下游产品
6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)
生产厂家
356783-10-3, 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%) 相关搜索:
- C10H15FN3O15P3xNa
- 化合物 T13075L
- 356783-10-3
- T 705RTP sodium,T705RTP sodium
- T-705RTP Sodium Salt (>75%)
- T-705RTP sodium
- 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>
- 6-Fluoro-3,4-dihydro-4-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-3-oxo-pyrazinecarboxamide Sodium Salt (>75%)